NCT05867771 2023-05-22A Study of PM1022 in Patients With Advanced TumorsBiotheus Inc.Phase 1/2 Unknown200 enrolled
NCT05213767 2022-01-28Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Unknown190 enrolled
NCT03908814 2019-10-31Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant TumorsDragonboat Biopharmaceutical Company LimitedPhase 1 Unknown130 enrolled